ARQT

Arcutis Biotherapeutics, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$27.53

Price (1 Year)

$32.07 $20.86

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %5.9 / %30
Non-compliant assets / Total market cap %12.5 / %30
Non-compliant revenue / Total income %1.9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis.

Website

Analysis (Turkish): ARQT Hissesi Caiz mi, Helal mi? Arcutis Biotherapeutics, Inc. Katılım Analizi